Quarterly statement as at 30 September 2020
5 November 2020
Christoph Jurecka
Image: Klaus Ohlenschläger / dpa Picture Alliance
Quarterly statement
as at 30 September 2020
1 | 2 | 3 | 4 | 5 |
Munich Re ERGO | Reinsurance Outlook | Backup |
Quarterly statement as at 30 September 2020 | 5 November 2020 | 2 |
Munich Re
1
Image: Vertigo3d / Getty ImagesiStockphoto
Munich Re - Financial highlights Q3 2020
Munich Re posts a decent Q3 result considering high major losses
Munich Re
Net result
€199m (€999m) Reinsurance result of €63m
impacted by COVID-19 related claims and other major losses - strong ERGO result of €136m
Return on investment1
2.7% (2.8%)
Reinsurance: 3.7% - benefited from disposal gains
Q3 2020 (9M 2020) | |||||||||||
Technical result | Investment result | Net result | |||||||||
€m | €m | €m | |||||||||
2,431 | 5,826 | 5,308 | 2,490 | ||||||||
606 | 2,150 1,691 | 865 | 999 | ||||||||
538 | 87 | 199 | |||||||||
Q3 | Q3 | 9M | 9M | Q3 | Q3 | 9M | 9M | Q3 | Q3 | 9M | 9M |
2019 | 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | 2020 |
ERGO: 2.1% - impacted by equity impairments and derivative losses
Shareholders' equity
€29.6bn (-3.1% vs. 31.12.)
Return on equity1: 3.6% (5.9%)
Solvency II ratio: 216%
Reinsurance
Life and Health: Technical result incl. fee income: €56m (€160m) - Negative COVID-19 impact of ~€100m in Q3
- net result of €86m (€153m)
Property-casualty: 112.2% (106.1%) - Major-loss ratio:
26.7% (21.0%); Reserve releases2: -4.0%(-4.0%) - net result of -€23m (€446m)
ERGO
L&H Germany: RoI: 2.2% (2.6%) - net result of €31m (€99m)
Property-casualty Germany: C/R: 90.9% (92.2%) - net result of €48m (€120m)
International: C/R: 92.5% (92.6%) - net result of €57m (€162m)
1 Annualised. 2 For prior-year basic losses. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 4 |
Munich Re - COVID-19
L&H reinsurance - Increase in COVID-19-related claims consistent with pandemic development in different regions
COVID-19 related losses in L&H reinsurance
- Losses dominated by far by the US
- Q3: ~€100m / 9M: ~€200m
- 9M includes COVID-19 related claims expected to be incurred by 30 September - no specific provisions for COVID-19-related deaths after 30 September established
- Limited loss activity on disability lines so far
Outlook/
Projection 2020
- Claims development depends on further mortality experience, esp. in North America
- As expected, portfolio mortality rates are well below that of the general population
- Each 5% of extra mortality claims in our book leads to excess annual claims cost of ~€200m1
- Still far away from 200-year event scenario2 of ~€1.4bn
- Risk of disability claims depends on economic development
- UK longevity is expected to offset UK mortality claims
1 Estimate based on a stress test with simplistic assumptions, e.g. no differentiation between markets, no specific age distributions of our exposure and lethality | Quarterly statement as at 30 September 2020 | 5 November 2020 | 5 |
of the pandemic.; only refers to mortality business. 2 Scenario based on the assumption of 10m incremental global deaths. |
Munich Re - COVID-19
P-C reinsurance - Continuous worsening of the pandemic leaving its mark in Q3
COVID-19 related losses in P-C Reinsurance
- Losses across various lines of business, contingency losses making up the largest share
- Q3: ~€700m / 9M: ~€2.1bn
- Material reserve increase in Q3 due to the continuous worsening of the pandemic and recent reintroduction of restrictions in many countries
- 9M figures include COVID-19-related claims incurred through 30 September, reserved cautiously across affected lines of business
- 9M: ~€300m in paid claims and client-reported case reserves in reinsurance, ~€1.8bn IBNR1
Outlook/
Projection 2020
- Risk of further contingency claims continues, depending on development of the pandemic
- Claims in other lines of business are also expected to increase
- BI: focus on non-damage BI policies - contract wording is crucial (e.g. FCA ruling provides a differentiated view)
- Less exposure to further deterioration expected in credit given government interventions and exposure management of our cedants
- Less exposed in workers' comp. and D&O
1 Including €540m claims (direct business) for which we gave confirmation of coverage in 9M 2020. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 6 |
Munich Re - Capitalisation
Capital position
Equity | €m | |||||
Equity 31.12.2019 | 30,576 | Change in Q3 | ||||
Consolidated result | 999 | 199 | ||||
Changes | ||||||
Dividend | -1,373 | 0 | ||||
Unrealised gains/losses | 1,158 | 372 | ||||
Exchange rates | -931 | -651 | ||||
Share buy-backs | -359 | 0 | ||||
Other | -429 | -45 | ||||
Equity 30.9.2020 | 29,641 | -125 | ||||
Unrealised gains/losses | Exchange rates | |
Fixed-interest securities | Devaluation of various currencies, | |
9M: €1,885m | Q3: €306m | mainly USD |
Non-fixed-interest securities | ||
9M: -€743m | Q3: €62m |
Capitalisation | €bn | |||
0.3 | 0.3 | 0.3 | 0.3 | |
0.3 | 3.8 | 5.0 | ||
3.9 | 3.7 | |||
3.7 |
13.2 | 12.6 | 15.1 | ||
12.0 | 11.9 | |||
26.5 | 30.6 | 29.1 | 29.8 | 29.6 |
2018 | 2019 | 31.3.2020 | 30.6.2020 | 30.9.2020 |
Debt leverage1 (%)
Senior and other debt
Subordinated debt
Equity
1 Strategic debt (senior, subordinated and other debt) divided by total capital (strategic debt + equity). | Quarterly statement as at 30 September 2020 | 5 November 2020 | 7 |
Munich Re - Investments
Investment portfolio
Investment portfolio1 | % Portfolio management in Q3 |
Land and buildings 4.9 (4.7)
Miscellaneous2 8.1 (8.1)
Shares, equity funds and participating interests3 5.9 (7.1)
TOTAL
€252bn
Fixed-interest securities 55.4 (53.9)
Loans
25.8 (26.1)
- Investments in longer term US and Australian government bonds as well as short-term bank bonds and ABS at the expense of covered bonds
- Slight expansion of equity exposure despite disposal of strategic equity investments
- Ongoing increase of infrastructure and private equity investments
- Drop in reinvestment yield to 1.3%
Portfolio duration1
Reinsurance
ERGO
Munich Re
DV011,4 | €m | ||||||||||||||
Assets Liabilities | Assets | Liabilities | Net | ||||||||||||
6.9 (6.5) | 7.4 (6.3) | 51 (46) | 41 (34) | 10 | |||||||||||
9.9 (9.4) | 10.6 (10.1) | 138 (126) | 151 (139) | -13 | |||||||||||
8.9 (8.4) | 9.7 (9.0) | 189 (172) | 192 (173) | -3 | |||||||||||
1 Fair values as at 30.9.2020 (31.12.2019). 2 Deposits retained on assumed reinsurance, deposits with banks, investment funds (excl. equities), derivatives | Quarterly statement as at 30 September 2020 | 5 November 2020 | 8 |
and investments in renewable energies and gold. 3 Net of hedges: 4.8% (6.4%). 4 Market value change due to a parallel downward shift in yield curve by |
one basis point, considering the portfolio size of assets and liabilities (pre-tax). Negative net DV01 means rising interest rates are beneficial.
Munich Re (Group) - Investments
Investment result
€m | Q3 2020 | Return1 | 9M 2020 | Return1 | 9M 2019 | Return1 | ||||||||||||||||||
Regular income | 1,536 | 2.4% | 4,801 | 2.6% | 5,133 | 2.8% | ||||||||||||||||||
Write-ups/write-downs | -265 | -0.4% | -1,832 | -1.0% | -285 | -0.2% | ||||||||||||||||||
Disposal gains/losses | 644 | 1.0% | 2,210 | 1.2% | 1,671 | 0.9% | ||||||||||||||||||
Derivatives2 | -65 | -0.1% | 629 | 0.3% | -208 | -0.1% | ||||||||||||||||||
Other income/expenses | -159 | -0.3% | -500 | -0.3% | -485 | -0.3% | ||||||||||||||||||
Investment result | 1,691 | 2.7% | 5,308 | 2.8% | 5,826 | 3.2% | ||||||||||||||||||
Total return | 3.8% | 4.4% | 12.1% | |||||||||||||||||||||
3-month | Write-ups/ | Disposal | Write-ups/ | Disposal | ||||||||||||||||||||
reinvestment yield | Q3 2020 | write-downs gains/losses Derivatives | 9M 2020 | write-downs | gains/losses | Derivatives | ||||||||||||||||||
Q3 2020 | 1.3% | Fixed income | -7 | 321 | 26 | Fixed income | -22 | 1,358 | 605 | |||||||||||||||
Q2 2020 | 1.6% | Equities | -207 | 318 | -103 | Equities | -1,671 | 551 | 78 | |||||||||||||||
Commodities/Inflation | -2 | 0 | 22 | Commodities/Inflation | 39 | 0 | 38 | |||||||||||||||||
Q1 2020 | 1.9% | Other | -50 | 5 | -10 | Other | -178 | 301 | -91 | |||||||||||||||
1 Annualised return on quarterly weighted investments (market values) in %. 2 Result from derivatives without regular income and other income/expenses. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 9 |
ERGO
2
Image: dem10 / iStockphoto Getty Images
ERGO
ERGO Life and Health Germany
Gross premiums written | €m | ||
9M 2019 | 6,912 | ||
Foreign exchange | -1 | ||
Divestments/investments | 0 | ||
Organic change | -193 | ||
9M 2020 | 6,718 | ||
▪ Life (-€80m): Growth through new products |
Major result drivers | €m | ||||||||
9M 2020 | 9M 2019 | | Q3 2020 | Q3 2019 | | ||||
Technical result | 331 | 234 | 96 | 306 | 81 | 225 | |||
Non-technical result | -56 | -28 | -28 | -166 | -128 | -38 | |||
thereof investment result | 2,454 | 2,985 | -531 | 697 | 985 | -288 | |||
Other | -175 | -63 | -112 | -110 | 54 | -164 | |||
Net result | 99 | 143 | -43 | 31 | 8 | 23 | |||
Technical result | Investment result |
only partially compensating for ordinary | |
attrition of back book | |
▪ | Health (-€141m): Increase in comprehensive |
and supplementary insurance, negative | |
COVID-19 effect in Travel | |
▪ | Digital Ventures (+€27m): Growth in health |
insurance (esp. dental products) |
- Q3: Interdependency between investment and technical result - COVID-19 leading to high intra-year volatility with positive impact in Q3
- 9M: Decrease in Travel due to COVID-19; improved result in Health
- 9M: Higher impairments of equities during volatile capital market environment due to COVID-19, partly offset by disposal gains and hedging
- Q3: Decrease driven by higher impairments and lower derivatives result; Return on investment of 2.2%
Other
-
FX result of -€91m in 9M (9M 2019: €54m),
thereof -€65m in Q3 (Q3 2019: €94m)
Quarterly statement as at 30 September 2020 | 5 November 2020 | 11 |
ERGO
ERGO Property-casualty Germany
Gross premiums written | €m | |
9M 2019 | 2,804 | |
Foreign exchange | 5 | |
Divestments/investments | 0 | |
Organic change | 134 | |
9M 2020 | 2,943 | |
Major result drivers | €m | |||||||
9M 2020 | 9M 2019 | | Q3 2020 | Q3 2019 | | |||
Technical result | 237 | 231 | 6 | 92 | 81 | 11 | ||
Non-technical result | -34 | -80 | 47 | -14 | -20 | 6 | ||
thereof investment result | 122 | 105 | 17 | 29 | 34 | -5 | ||
Other | -84 | -46 | -38 | -30 | -26 | -4 | ||
Net result | 120 | 105 | 15 | 48 | 36 | 13 |
- Organic growth in almost all lines of business; mainly driven by fire/property (+€43m), liability (+€29m), motor (+€24m) and other insurance (+€35m)
Technical result
Combined ratio of 92.2% in 9M at guidance level, 90.9% in Q3 due to
- Strong premium development
- Nat-catlosses significantly below expectations
- Minor COVID-19 effects from business closure and event cancellation; lower costs
Investment result
- 9M: Disposal gains and hedging more than offset impairments on equities
- Q3: Disposal gains partly offset impairments on equities and lower derivatives result
- Q3: Return on investment of 1.5%
Quarterly statement as at 30 September 2020 | 5 November 2020 | 12 |
ERGO
ERGO Property-casualty Germany
Combined ratio | % Gross premiums written in 9M 2020 (9M 2019) | €m |
- Loss ratio ◼ Expense ratio
2018 | 96.0 | 62.5 | 33.4 | |
2019 | 92.3 | 60.3 | 32.0 | |
9M 2020 | 92.2 | 61.6 | 30.6 | |
Q3 2020 | 90.9 | 61.9 | 29.0 | |
97.9 | 98.1 | ||||
92.1 | 93.2 | 93.4 | 92.5 | 90.9 | |
86.2 |
Other | Motor |
259 (224) | 617 (593) |
Marine 182 (165)
TOTAL | Fire/property |
€2,943m | |
585 (542) | |
(€2,804m) | |
Legal protection 316 (318)
Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Personal accident | Liability |
449 (458) | 534 (505) | ||||||||
2018 | 2019 | 2019 | 2019 | 2019 | 2020 | 2020 | 2020 |
Quarterly statement as at 30 September 2020 | 5 November 2020 | 13 |
ERGO
ERGO International
Gross premiums written | €m | |
9M 2019 | 3,657 | |
Foreign exchange | -32 | |
Divestments/investments | -103 | |
Organic change | 63 | |
9M 2020 | 3,584 | |
▪ Life (-€37m): Lower level due to run-down in |
Major result drivers | €m | |||||||
9M 2020 | 9M 2019 | | Q3 2020 | Q3 2019 | | |||
Technical result | 189 | 191 | -2 | 78 | 96 | -18 | ||
Non-technical result | 20 | 1 | 19 | 1 | 44 | -42 | ||
thereof investment result | 260 | 298 | -38 | 81 | 138 | -57 | ||
Other | -47 | -100 | 53 | -22 | -64 | 42 | ||
Net result | 162 | 92 | 70 | 57 | 76 | -19 | ||
Technical result | Investment result |
Belgium and reduced new business in Austria |
related to COVID-19 |
▪ Health (+€66m): Positive business |
development in Spain and Belgium |
▪ P-C (-€102m): Decrease mainly driven by |
portfolio streamlining in 2019, lower growth in |
Poland due to COVID-19 |
Highlights in Q3:
- Life: Decrease driven by Belgium
- Health: Good quarter due to seasonal effects, tariff increases and favourable claims development
- P-C: Ongoing good operational performance (esp. Poland, Baltics), reduced attritional claims and lower large losses
- 9M/Q3: Previous year impacted by disposal gains due to portfolio streamlining
- Q3: Return on investment of 1.6%
Other
-
FX result of €0m in 9M (9M 2019: -€57m),
thereof €1m in Q3 (Q3 2019: -€38m)
Quarterly statement as at 30 September 2020 | 5 November 2020 | 14 |
ERGO
ERGO International
Combined ratio
% Gross premiums written in 9M 2020 (9M 2019) | €m |
94.5 | 95.4 | 95.0 | 91.8 | 94.8 | 95.2 | |
90.1 | ||||||
Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 |
2018 | 2019 | 2019 | 2019 | 2019 | 2020 | 2020 |
9M 2020
91.7 89.6 89.7 89.4 85.5 101.4
Poland Spain Austria Baltics Greece Legal protection
Property-casualty1,985 (2,087)
92.5 | TOTAL | ||||||||
€3,584m | |||||||||
(€3,657m) | |||||||||
Q3 | |||||||||
2020 | |||||||||
P-C | 9M | 9M | Life | ||||||
92.6 | thereof: | 2020 | 2019 | thereof: | |||||
Poland | 1,056 | 1,080 | Austria | ||||||
Belgium | |||||||||
Legal protection | 497 | 476 | |||||||
Greece | 180 | 173 | Health | ||||||
Baltics | 145 | 144 | thereof: | ||||||
Spain | |||||||||
Total | Austria | 79 | 74 | ||||||
Belgium | |||||||||
Life 470 (507)
Health 1,129 (1,062)
9M 9M
2020 2019
- 266
- 114
9M 9M
2020 2019
- 615
- 448
Quarterly statement as at 30 September 2020 | 5 November 2020 | 15 |
Reinsurance
3
Image: John Lund Getty Images
Reinsurance
Reinsurance - Life and Health
Gross premiums written | €m | |
9M 2019 | 8,625 | |
Foreign exchange | -33 | |
Divestments/investments | 0 | |
Organic change | 946 | |
9M 2020 | 9,538 | |
Major result drivers | €m | |||||||
9M 2020 | 9M 2019 | | Q3 2020 | Q3 2019 | | |||
Technical result | 31 | 322 | -291 | 10 | 194 | -184 | ||
Non-technical result | 207 | 369 | -162 | 110 | 103 | 7 | ||
thereof investment result | 639 | 866 | -227 | 239 | 279 | -40 | ||
Other | -85 | -75 | -10 | -34 | -15 | -19 | ||
Net result | 153 | 617 | -464 | 86 | 282 | -196 | ||
- Organic growth mainly in Asia and Europe, but also some growth across North America
- Asia: Several new transactions and increases of shares/volumes under existing treaties
- Europe: Positive impact from longevity transactions concluded in Q2
Technical result incl. fee income of €56m (€160m)
- COVID-19-relatedclaims of ~€100m in Q2 and again inQ3, dominated by US mortality
- In North America: non-COVID-19-related claims higher than expected and some impact from lower interest rates on claims reserves …
- … largely offset by strong results in
Europe and Asia as well as better-than- expected performance in Australia - Ongoing pleasing fee income
Investment result
- 9M/Q3: Disposal gains on fixed income investments from ordinary portfolio turnover clearly exceed write-downs on equities from H1
- Q3: Positive one-off effect from disposal of strategic equity investments
- Q3: Return on investment: 3.2%
Other
-
FX result of -€5m in 9M (9M 2019: €83m),
thereof -€19m in Q3 (Q3 2019: €41m)
Quarterly statement as at 30 September 2020 | 5 November 2020 | 17 |
Reinsurance
Reinsurance - Property-casualty
Gross premiums written | €m | |
9M 2019 | 16,920 | |
Foreign exchange | -17 | |
Divestments/investments | 0 | |
Organic change | 1,576 | |
9M 2020 | 18,479 | |
- Organic growth across almost all lines driven by business expansion and rate increases in traditional reinsurance …
- … as well as in our Risk Solutions portfolio
Major result drivers | €m | |||||||
9M 2020 | 9M 2019 | | Q3 2020 | Q3 2019 | | |||
Technical result | -182 | 1,453 | -1,635 | -399 | 87 | -486 | ||
Non-technical result | 762 | 341 | 421 | 334 | 306 | 28 | ||
thereof investment result | 1,834 | 1,572 | 261 | 646 | 715 | -69 | ||
Other | -115 | -259 | 144 | 42 | 71 | -29 | ||
Net result | 466 | 1,535 | -1,069 | -23 | 464 | -486 | ||
Technical result | Investment result |
- COVID-19-relatedclaims of ~€2.1bn in ▪ 9M: Gains on fixed-income/ real estate disposals
9M (thereof ~€0.7bn in Q3), contingency | and derivatives clearly exceed write-downs on |
business accounts for the largest share | equities |
▪ Expense ratio improved due to cost | ▪ Q3: Disposal gains on fixed income and strategic |
reductions and premium growth | equity investments |
▪ Underlying performance remains very | ▪ Q3: Return on investment: 3.9% |
strong - normalised combined ratio at | Other |
~97% in Q3 and 9M | |
▪ FX result of €170m in 9M (9M 2019: €251m), | |
thereof -€20m in Q3 (Q3 2019: €137m) |
Quarterly statement as at 30 September 2020 | 5 November 2020 | 18 |
Reinsurance
Reinsurance - Property-casualty
Combined ratio
%
◼ Basic losses | ◼ Major losses | ◼ Expense ratio |
111.6112.2
105.1 | 103.9 | 106.0 |
97.3
99.9
86.9
Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 |
2018 | 2019 | 2019 | 2019 | 2019 | 2020 | 2020 | 2020 |
2018 | 99.4 | 53.6 | 11.6 | 34.2 | ||||
100.2 | ||||||||
2019 | 51.4 | 15.2 | 33.6 | |||||
106.1 | ||||||||
9M 2020 | 54.8 | 21.0 | 30.3 | |||||
112.2 | ||||||||
Q3 2020 | 55.6 | 26.7 | 29.9 | |||||
Major | Reserve | Normalised | ||||||||
losses | Nat cat | Man-made | releases1 | combined ratio2 | ||||||
9M 2020 | 21.0 | 5.1 | 15.9 | -4.0 | 97.0 | |||||
Q3 2020 | 26.7 | 8.3 | 18.4 | -4.0 | 97.0 | |||||
Ø Annual | ~12.0 | ~8.0 | ~4.0 | ~-4.0 | ||||||
expectation | ||||||||||
1 Basic losses prior years, already adjusted for directly corresponding sliding-scale and profit-commission effects. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 19 |
2 Based on reserve releases of 4%-pts. Normalised combined ratio reflects a one-off shift between commissions and non-technical result of €29m in Q3 2020 |
(corresponding to -0.5%-pts. in Q3 and -0.2%-pts. in 9M).
Outlook
4
Image: Klaus Ohlenschläger / dpa Picture Alliance
Outlook 2020
Group
Gross premiums written
~€54bn
ERGO
Gross premiums written1
~17.5bn
Reinsurance
Gross premiums written
~€36bn
Net result
withdrawn
Net result1
~€530m
Net result
withdrawn
Return on investment1
~3%
Combined ratio | |
P-C Germany1 | International1 |
~92% | ~94% |
Combined ratio | Technical result, incl. fee income |
Property-casualty | Life and Health |
withdrawn | withdrawn |
1 Substantial risk of falling short of this guidance, subject to the further development of the COVID-19 pandemic. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 21 |
Backup
5
Image: imaginima / Getty Images
Backup: Group finance and risk
Segment income statement Q3 2020
€m | Reinsurance | Reinsurance | ERGO | ERGO | ERGO | Total |
L/H1 | P-C | L/H Germany | P-C Germany | International | Q3 2020 | |
Gross premiums written | 3,127 | 6,798 | 2,254 | 808 | 1,162 | 14,150 |
Net earned premiums | 2,844 | 5,680 | 2,254 | 917 | 1,133 | 12,827 |
Income from technical interest | 169 | 286 | 904 | 17 | 94 | 1,470 |
Net expenses for claims and benefits | -2,504 | -4,666 | -2,482 | -576 | -844 | -11,072 |
Net operating expenses | -499 | -1,698 | -369 | -266 | -305 | -3,137 |
Technical result | 10 | -399 | 306 | 92 | 78 | 87 |
Investment result | 239 | 646 | 697 | 29 | 81 | 1,691 |
Insurance-related investment result | 24 | -10 | 116 | 0 | 46 | 175 |
Other operating result | 17 | -16 | -75 | -26 | -31 | -131 |
Deduction of income from technical interest | -169 | -286 | -904 | -17 | -94 | -1,470 |
Non-technical result
Operating result
110 | 334 | -166 | -14 | 1 | 265 |
120 | -65 | 140 | 78 | 79 | 353 |
Other non-operating result | 1 | -2 | -29 | -7 | 5 | -31 | ||||||
Currency result | -19 | -20 | -65 | 4 | 1 | -100 | ||||||
Net finance costs | -10 | -31 | -6 | -2 | -7 | -54 | ||||||
Taxes on income | -6 | 96 | -10 | -25 | -22 | 32 | ||||||
Net result | 86 | -23 | 31 | 48 | 57 | 199 | ||||||
Tax rate | 7.0% | 80.8% | 24.8% | 33.9% | 27.7% | -19.4% |
1 Technical result incl. fee income: €56m. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 23 |
Backup: Group finance and risk
Segment income statement 9M 2020
€m | Reinsurance | Reinsurance | ERGO | ERGO | ERGO | Total |
L/H1 | P-C | L/H Germany | P-C Germany | International | 9M 2020 | |
Gross premiums written | 9,538 | 18,479 | 6,718 | 2,943 | 3,584 | 41,261 |
Net earned premiums | 8,575 | 16,668 | 6,743 | 2,635 | 3,367 | 37,988 |
Income from technical interest | 501 | 837 | 2,010 | 51 | 55 | 3,455 |
Net expenses for claims and benefits | -7,491 | -12,634 | -7,379 | -1,642 | -2,306 | -31,453 |
Net operating expenses | -1,554 | -5,053 | -1,043 | -806 | -927 | -9,383 |
Technical result | 31 | -182 | 331 | 237 | 189 | 606 |
Investment result | 639 | 1,834 | 2,454 | 122 | 260 | 5,308 |
Insurance-related investment result | 34 | -43 | -276 | 0 | -89 | -374 |
Other operating result | 35 | -192 | -223 | -105 | -96 | -580 |
Deduction of income from technical interest | -501 | -837 | -2,010 | -51 | -55 | -3,455 |
Non-technical result
Operating result
207 | 762 | -56 | -34 | 20 | 899 |
238 | 580 | 275 | 203 | 209 | 1,505 |
Other non-operating result | 1 | -10 | -32 | -12 | 5 | -48 | ||||||
Currency result | -5 | 170 | -91 | -7 | 0 | 67 | ||||||
Net finance costs | -29 | -93 | -16 | -5 | -20 | -164 | ||||||
Taxes on income | -51 | -181 | -36 | -60 | -32 | -360 | ||||||
Net result | 153 | 466 | 99 | 120 | 162 | 999 | ||||||
Tax rate | 25.0% | 28.0% | 26.4% | 33.5% | 16.7% | 26.5% |
1 Technical result incl. fee income: €160m. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 24 |
Backup: Group finance and risk
Actual vs. analysts' consensus
Operating result - Actual vs. analysts' consensus1 | €m | KPIs - Actual vs. analysts' consensus1 | €m | |||||||||||||
Q3 2020 | Consensus Difference | Q3 2020 | Consensus | Impact2 | ||||||||||||
Reinsurance Property-casualty | -65 | -57 | -8 | Combined ratio | 112.2% | 109.2% | -172 | |||||||||
Reinsurance Life and Health | 120 | 98 | 22 | Tech. result incl. fee income | €56m | |||||||||||
ERGO Life and Health Germany | 140 | 132 | 8 | |||||||||||||
ERGO Property-casualty Germany | 78 | 87 | -9 | Combined ratio | 90.9% | 91.8% | 8 | |||||||||
ERGO International | 79 | 82 | -3 | Combined ratio | 92.5% | 94.4% | 16 | |||||||||
Operating result | 353 | 342 | 11 | |||||||||||||
RoI by segment - Actual vs. analysts' consensus
FX | -100 | Reinsurance P-C | ||||||
Other | -86 | Reinsurance L&H | ||||||
ERGO L&H Germany | ||||||||
Taxes | 32 | |||||||
ERGO P-C Germany | ||||||||
Net result | 199 | 195 | 4 | ERGO International |
3.9% | Presumably | |
3.2% | above consensus | |
2.2% | Presumably | |
1.5% | ||
below consensus | ||
1.6% | ||
1 Simple average of estimates the Munich Re Investor Relations team has gathered from analysts covering Munich Re, not taking into account any external | Quarterly statement as at 30 September 2020 | 5 November 2020 | 25 |
data providers. 2 Difference between actual and consensus times net earned premiums. |
Backup: Group finance and risk
Premium development
Gross premiums written | €m | |||
38,917 | ||||
9M 2019 | ||||
Foreign | -78 | |||
exchange | ||||
Divestments/ | -103 | |||
investments | ||||
Organic | 2,526 | |||
change | ||||
9M 2020 | 41,261 |
Segmental breakdown
Reinsurance
Property-casualty
18,479 (45%) ( 9.2%)
TOTAL
€41.3bn
Reinsurance
Life and Health
9,538 (23%) ( 10.6%)
€m
ERGO Life and Health Germany
6,718 (16%) ( -2.8%)
ERGO Property-casualty Germany
2,943 (7%) ( 4.9%)
ERGO
International
3,584 (9%) ( -2.0%)
Quarterly statement as at 30 September 2020 | 5 November 2020 | 26 |
Backup: Reinsurance
Development of combined ratio
Combined ratio vs. basic losses (%)
Combined ratio
Basic loss ratio
103.9 | 88.6 | 102.0 | 100.7 | 105.1 | 97.3 | 86.9 | 103.9 | 111.6 | 106.0 | 99.9 | 112.2 |
55.6 | 53.2 | 55.7 | 55.3 | 50.4 | 54.8 | 50.1 | 54.7 | 46.4 | 54.7 | 54.1 | 55.6 |
Q4 2017 | Q1 2018 | Q2 2018 | Q3 2018 | Q4 2018 | Q1 2019 | Q2 2019 | Q3 2019 | Q4 2019 | Q1 2020 | Q2 2020 | Q3 2020 |
Nat cat vs. man-made(%)
Nat cat ratio | |||||||||||
12.0 | Man-made ratio | 14.1 | 21.1 | 17.4 | 11.7 | ||||||
11.0 | 10.5 | 5.7 | 10.8 | ||||||||
2.6 | 3.1 | ||||||||||
0.0 | -1.1 | 2.3 | 2.0 | 3.8 | 4.0 | 0.9 | 7.6 | 6.3 | 3.7 | 3.1 | |
18.4
8.3
Q4 2017 | Q1 2018 | Q2 2018 | Q3 2018 | Q4 2018 | Q1 2019 | Q2 2019 | Q3 2019 | Q4 2019 | Q1 2020 | Q2 2020 | Q3 2020 |
Quarterly statement as at 30 September 2020 | 5 November 2020 | 27 |
Backup: Group finance and risk - Investments
Return on investment by asset class and segment
9M 2020
%1 | Regular | Write-ups/ | Disposal | Extraord. | Other | ᴓ Market | |||||||||||||||
income | -downs | result | derivatives result | inc./exp. | RoI | value (€m) | |||||||||||||||
Afs fixed-income | 2.0 | 0.0 | 1.0 | - | - | 3.0 | 134,700 | ||||||||||||||
Afs non-fixed-income | 4.8 | -13.4 | 4.4 | - | - | -4.2 | 16,599 | ||||||||||||||
Derivatives | 4.0 | - | - | 27.5 | -1.1 | 30.4 | 3,048 | ||||||||||||||
Loans | 2.7 | 0.0 | 0.7 | - | - | 3.4 | 64,917 | ||||||||||||||
Real estate | 4.6 | -1.2 | 3.2 | - | - | 6.6 | 12,173 | ||||||||||||||
Other2 | 2.6 | -0.3 | 0.1 | - | -3.6 | -1.1 | 17,637 | ||||||||||||||
Total | 2.6 | -1.0 | 1.2 | 0.3 | -0.3 | 2.8 | 249,073 | ||||||||||||||
Reinsurance | 2.6 | -0.4 | 1.1 | 0.5 | -0.3 | 3.5 | 95,282 | ||||||||||||||
ERGO | 2.6 | -1.3 | 1.2 | 0.2 | -0.2 | 2.5 | 153,791 | ||||||||||||||
3.4% | Return on investment | Average 3.0% | 3.2% | 3.4% | 3.2% | 3.1% | |||||||||||||||
3.1% | 3.1% | 3.0% | 2.7% | ||||||||||||||||||
2.9% | 2.7% | ||||||||||||||||||||
2.3% | |||||||||||||||||||||
Q4 2017 | Q1 2018 | Q2 2018 | Q3 2018 | Q4 2018 | Q1 2019 | Q2 2019 | Q3 2019 | Q4 2019 | Q1 2020 | Q2 2020 | Q3 2020 |
1 Annualised. 2 Including management expenses. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 28 |
Backup: Investments
Investment result - Reinsurance
Reinsurance Life and Health (€m) | Q3 2020 | Return1 | 9M 2020 | Return1 | 9M 2019 | Return1 | ||||
Regular income | 186 | 2.5% | 572 | 2.6% | 600 | 2.9% | ||||
Write-ups/write-downs | -4 | 0.0% | -18 | -0.1% | 0 | 0.0% | ||||
Disposal gains/losses | 80 | 1.1% | 130 | 0.6% | 274 | 1.3% | ||||
Derivatives2 | -3 | 0.0% | 17 | 0.1% | 4 | 0.0% | ||||
Other income/expenses | -21 | -0.3% | -63 | -0.3% | -13 | -0.1% | ||||
Investment result | 239 | 3.2% | 639 | 2.9% | 866 | 4.1% | ||||
Average market value | 29,675 | 29,499 | 27,961 | |||||||
Reinsurance Property-casualty(€m) | Q3 2020 | Return1 | 9M 2020 | Return1 | 9M 2019 | Return1 | ||||
Regular income | 414 | 2.5% | 1,268 | 2.6% | 1,420 | 3.0% | ||||
Write-ups/write-downs | -57 | -0.3% | -281 | -0.6% | -114 | -0.2% | ||||
Disposal gains/losses | 322 | 2.0% | 682 | 1.4% | 444 | 0.9% | ||||
Derivatives2 | 25 | 0.2% | 345 | 0.7% | 10 | 0.0% | ||||
Other income/expenses | -58 | -0.4% | -180 | -0.4% | -187 | -0.4% | ||||
Investment result | 646 | 3.9% | 1,834 | 3.7% | 1,572 | 3.3% | ||||
Average market value | 65,694 | 65,783 | 63,310 | |||||||
1 Return on quarterly weighted investments (market values) in % p.a. 2 Result from derivatives without regular income and other income/expenses. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 29 |
Backup: Investments
Investment result - ERGO
Life and Health Germany (€m) | Q3 2020 | Return1 | 9M 2020 | Return1 | 9M 2019 | Return1 | |||||||
Regular income | 819 | 2.6% | 2,587 | 2.7% | 2,722 | 2.9% | |||||||
Write-ups/write-downs | -182 | -0.6% | -1,426 | -1.5% | -180 | -0.2% | |||||||
Disposal gains/losses | 217 | 0.7% | 1,280 | 1.3% | 827 | 0.9% | |||||||
Derivatives2 | -78 | -0.2% | 244 | 0.3% | -137 | -0.1% | |||||||
Other income/expenses | -78 | -0.2% | -231 | -0.2% | -248 | -0.3% | |||||||
Investment result | 697 | 2.2% | 2,454 | 2.6% | 2,985 | 3.2% | |||||||
Average market value | 128,327 | 127,160 | 125,888 | ||||||||||
Property-casualty Germany (€m) | Q3 2020 | Return1 | 9M 2020 | Return1 | 9M 2019 | Return1 | |||||||
Regular income | 35 | 1.8% | 115 | 2.0% | 119 | 2.1% | |||||||
Write-ups/write-downs | -19 | -1.0% | -82 | -1.5% | -23 | -0.4% | |||||||
Disposal gains/losses | 17 | 0.9% | 91 | 1.6% | 73 | 1.3% | |||||||
Derivatives2 | -7 | -0.4% | 6 | 0.1% | -44 | -0.8% | |||||||
Other income/expenses | 4 | 0.2% | -8 | -0.1% | -19 | -0.3% | |||||||
Investment result | 29 | 1.5% | 122 | 2.2% | 105 | 1.9% | |||||||
Average market value | 7,566 | 7,520 | 7,495 |
1 Return on quarterly weighted investments (market values) in % p.a. 2 Result from derivatives without regular income and other income/expenses. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 30 |
Backup: Investments
Investment result - ERGO
International (€m) | Q3 2020 | Return1 | 9M 2020 | Return1 | 9M 2019 | Return1 | |||
Regular income | 83 | 1.7% | 259 | 1.8% | 273 | 2.0% | |||
Write-ups/write-downs | -4 | -0.1% | -25 | -0.2% | 32 | 0.2% | |||
Disposal gains/losses | 9 | 0.2% | 28 | 0.2% | 53 | 0.4% | |||
Derivatives2 | -2 | 0.0% | 17 | 0.1% | -41 | -0.3% | |||
Other income/expenses | -6 | -0.1% | -18 | -0.1% | -19 | -0.1% | |||
Investment result | 81 | 1.6% | 260 | 1.8% | 298 | 2.2% | |||
Average market value | 19,630 | 19,110 | 18,097 | ||||||
1 Return on quarterly weighted investments (market values) in % p.a. 2 Result from derivatives without regular income and other income/expenses. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 31 |
Backup: Investments
Sensitivities to interest rates, spreads and equities1
Sensitivity to risk-free interest in €bn (change in basis points) | -50bps-25bps +50bps | +100bps | ||||||
Change in market value, gross | +10.2 | +5.0 | -9.2 | -17.4 | ||||
Change in on-balance-sheet reserves, net | +2.8 | +1.4 | -2.6 | -4.9 | ||||
Change in off-balance-sheet reserves, net | +0.4 | +0.2 | -0.4 | -0.8 | ||||
P&L (Investment result), gross | +0.4 | +0.2 | -0.4 | -0.8 | ||||
P&L, net | +0.2 | +0.1 | -0.2 | -0.4 | ||||
Sensitivity to spreads2 in €bn (change in basis points) | +50bps | +100bps | ||||||
Change in market value, gross | -6.2 | -11.7 | ||||||
Change in on-balance-sheet reserves, net | -1.5 | -2.8 | ||||||
Change in off-balance-sheet reserves, net | -0.3 | -0.5 | ||||||
P&L (Investment result), gross | -0.3 | -0.6 | ||||||
P&L, net | -0.1 | -0.2 | ||||||
Sensitivity to share prices3 in €bn (change in %) | -30% | -10% | +10% | +30% | ||||
Change in market value, gross | -1.7 | -0.7 | +0.6 | +1.4 | ||||
Change in on-balance-sheet reserves, net | -0.5 | -0.2 | +0.4 | +1.1 | ||||
P&L (Investment result), gross | -0.8 | -0.4 | -0.3 | -1.4 | ||||
P&L, net | -0.4 | -0.2 | -0.0 | -0.2 |
1 Rough calculation with limited reliability assuming unchanged portfolio as at 30.9.2020. After rough estimation of policyholder participation and deferred tax; | |||
linearity of relations cannot be assumed. Approximation - not fully comparable with IFRS figures. 2 Sensitivities to changes of spreads are calculated for | Quarterly statement as at 30 September 2020 | 5 November 2020 | 32 |
every category of fixed income portfolio, except government securities with AAA ratings. 3 Sensitivities to change in share prices are calculated for listed |
shares only; assumptions: equity impairments as soon as market value drops below acquisition cost and best-estimate calculation of hedging impact.
Backup: Investments
On- and off-balance-sheet reserves
€m | 31.12. | 31.12. | 30.6. |
2018 | 2019 | 2020 | |
Market value of investments | 231,876 | 247,310 | 249,858 |
Total reserves | 22,002 | 33,120 | 35,321 |
On-balance-sheet reserves | |||
Fixed-interest securities | 4,953 | 10,738 | 13,058 |
Non-fixed-interest securities | 1,817 | 3,632 | 2,355 |
Other on-balance-sheet reserves1 | 207 | 203 | 130 |
Subtotal | 6,977 | 14,574 | 15,544 |
Off-balance-sheet reserves |
30.9.
2020 | in Q3 |
251,928 | 2,070 |
36,040 | 719 |
13,867 | 809 |
2,366 | 11 |
130 | 0 |
16,364 | 820 |
Real estate2 | 4,769 | 5,600 | 5,631 | 5,668 | 37 | ||||||
Loans3 | 9,453 | 12,147 | 13,292 | 13,079 | -213 | ||||||
Associates | 803 | 799 | 855 | 930 | 75 | ||||||
Subtotal | 15,024 | 18,546 | 19,778 | 19,676 | -101 | ||||||
Reserve ratio | 9.5% | 13.4% | 14.1% | 14.3% | 0.2 pp | ||||||
1 | Unrealised gains/losses from unconsolidated affiliated companies, valuation at equity and cash-flow hedging. | Quarterly statement as at 30 September 2020 | 5 November 2020 33 | ||||||||
2 | Excluding reserves from owner-occupied property. 3 Excluding insurance-related loans. |
Backup: Investments
On- and off-balance-sheet reserves
€m | On-balance-sheet reserves | Off-balance-sheet reserves1 | ||
Total reserves (gross) | 16,364 | 19,676 | ||
Provision for deferred premium refunds | -6,501 | -11,690 | ||
Deferred tax | -2,295 | -2,439 | ||
Minority interests | -9 | - | ||
Consolidation and currency effects | -101 | - | ||
Shareholders' stake | 7,458 | 5,547 | ||
1 Excluding reserves for owner-occupied property and insurance-related loans. | Quarterly statement as at 30 September 2020 | 5 November 2020 | 34 |
Backup: Shareholder information
Changes to shares in circulation
Acquisition of | Retirement of | 30.9. | ||||||
Shares | 31.12. own shares in | own shares in | ||||||
2020 | ||||||||
(millions) | 2019 | 9M 2020 | 9M 2020 | |||||
Shares in | 141.5 | -1.4 | - | 140.1 | ||||
circulation | ||||||||
Treasury | 2.9 | 1.4 | -4.2 | - | ||||
shares | ||||||||
Total | 144.3 | - | -4.2 | 140.1 | ||||
Weighted average number of shares in circulation (millions)
148.7 | 143.6 | 140.3 | 140.1 |
2018 | 2019 | 9M 2020 | Q3 2020 |
Quarterly statement as at 30 September 2020 | 5 November 2020 | 35 |
Backup: Shareholder information
Financial calendar
2020
8 December
2021
25 FEBRUARY
17 MARCH
28 APRIL
6 MAY
10 AUGUST
9 NOVEMBER
Investor Day
Balance sheet media conference for 2020 financial statements Analysts' and Investors' call
Annual report (Group), Annual report (Company) Annual General Meeting 2021
Quarterly statement as at 31 March 2021
Half-year financial report as at 30 June 2021
Quarterly statement as at 30 September 2021
Quarterly statement as at 30 September 2020 | 5 November 2020 | 36 |
Backup: Shareholder information
For information, please contact
Investor Relations Team
Christian Becker-Hussong | Thorsten Dzuba | Christine Franziszi |
Head of Investor & Rating Agency Relations | Tel.: +49 (89) 3891-8030 | Tel.: +49 (89) 3891-3875 |
Tel.: +49 (89) 3891-3910 | Email: tdzuba@munichre.com | Email: cfranziszi@munichre.com |
Email: cbecker-hussong@munichre.com | ||
Ralf Kleinschroth | Andreas Silberhorn (Rating agencies) | Ingrid Grunwald (ESG) |
Tel.: +49 (89) 3891-4559 | Tel.: +49 (89) 3891-3366 | Tel.: +49 (89) 3891-3517 |
Email: rkleinschroth@munichre.com | Email: asilberhorn@munichre.com | Email: igrunwald@munichre.com |
Maximiliane Gerstner (ERGO) | ||
Tel.: +49 (211) 477-7483 | ||
Email: maximiliane.gerstner@ergo.de |
Münchener Rückversicherungs-Gesellschaft | Investor & Rating Agency Relations | Königinstraße 107 | 80802 München, Germany
Fax: +49 (89) 3891-9888 | Email: IR@munichre.com | Internet: www.munichre.com
Quarterly statement as at 30 September 2020 | 5 November 2020 | 37 |
Disclaimer
This presentation contains forward-looking statements that are based on current assumptions and
forecasts of the management of Munich Re. Known and unknown risks, uncertainties and other factors could lead to material differences between the forward-looking statements given here and the actual development, in particular the results, financial situation and performance of our Company. Obvious fluctuations in
the incidence of major losses as well as pronounced volatility of the capital markets and exchange rates - as well as the special features of IFRS accounting make an accurate forecast of results impossible. Moreover, there is considerable uncertainty regarding the further development of the coronavirus pandemic. The Company assumes no liability to update these forward-lookingstatements or to make them conform
to future events or developments. Figures from Q1 2019 onwards are restated reflecting the new cost- allocation method.
Quarterly statement as at 30 September 2020 | 5 November 2020 | 38 |
Attachments
- Original document
- Permalink
Disclaimer
Munich Re Group - Münchener Rück AG published this content on 05 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 November 2020 08:41:08 UTC